{"id":"W2763294721","doi":"10.1093/annonc/mdx367.008","title":"A first in human phase 1 study of KPT-9274, a first in class dual inhibitor of PAK4 and NAMPT, in patients with advanced solid malignancies or NHL","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Pharmacodynamics; Nicotinamide phosphoribosyltransferase; Internal medicine; Adverse effect; Nausea; Anemia; Pharmacology; Gastroenterology; Pharmacokinetics; Oncology; NAD+ kinase; Enzyme; Biochemistry; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001643838,0.001951474,0.003060695,0.0005848221,0.0007888855,0.001615995,0.001054127,0.001610607,0.0069814],"category_scores_gemma":[0.001319537,0.0009238604,0.002159792,0.000563533,0.001027175,0.001080333,0.0004353852,0.006460664,0.001898487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001224429,"about_ca_system_score_gemma":0.002305977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002411467,"about_ca_topic_score_gemma":0.008624562,"domain_scores_codex":[0.9995545,0.0001886727,0.00001633795,0.00006617925,0.00003834719,0.0001359312],"domain_scores_gemma":[0.9991849,0.0001431102,0.00008148827,0.0000783381,0.0000687981,0.0004432775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4531443,0.1309888,0.009275022,0.00285517,0.005965876,0.0008807808,0.000983974,0.007432539,0.07908028,0.001423652,0.04452662,0.2634431],"study_design_scores_gemma":[0.4892679,0.470091,0.01034944,0.0001142086,0.00174839,0.0007402723,0.0001959967,0.001770195,0.007660377,0.0008266385,0.01715401,0.00008156854],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9589902,0.009180882,0.003608814,0.003535978,0.0007846057,0.006570708,0.008794608,0.0007575889,0.007776687],"genre_scores_gemma":[0.9502087,0.008947017,0.007690358,0.004546992,0.0004389632,0.005009396,0.01180896,0.0002471727,0.01110258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0069814,"threshold_uncertainty_score":0.02335513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08063440243014508,"score_gpt":0.4291862201817902,"score_spread":0.3485518177516451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}